Dbv Technologies ADR (DBVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DBVT | AMGN | BMY | VRTX | GILD |
| Company | Dbv Technologies ADR | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 4.60 | 272.66 | 56.49 | 427.89 | 92.63 |
| High | 4.74 | 275.02 | 57.39 | 432.60 | 93.31 |
| Low | 4.54 | 272.07 | 55.95 | 424.65 | 91.84 |
| Last | 4.74 | 273.44 | 57.09 | 428.00 | 93.04 |
| Change | +0.22 | -1.37 | +0.05 | +0.11 | +0.08 |
| % Change | +4.87% | -0.50% | +0.09% | +0.03% | +0.09% |
| Volume | 16,100 | 3,518,300 | 8,439,801 | 1,215,700 | 7,285,700 |
| 20-Day Average Volume | 140,735 | 3,438,980 | 10,382,065 | 1,738,115 | 6,738,040 |
| Previous Close | 4.52 | 274.81 | 57.04 | 427.89 | 92.96 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.88 | 265.06 | 56.73 | 411.08 | 91.99 |
| 20-Day Raw Stochastic | 72.75% | 82.28% | 63.96% | 90.02% | 74.75% |
| 20-Day Relative Strength | 60.17% | 49.67% | 52.41% | 48.29% | 55.39% |
| Weighted Alpha | -68.64 | -14.30 | +20.38 | -4.58 | +24.86 |
| Today's Opinion | 24% Buy | 80% Sell | 56% Buy | 72% Sell | 80% Buy |
| Previous Opinion | 16% Buy | 80% Sell | 56% Buy | 72% Sell | 80% Buy |
| Last Month's Opinion | 88% Sell | 88% Sell | 80% Buy | 56% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.16% since 01/14/25 | +2.37% since 01/14/25 | +2.42% since 01/14/25 | +3.97% since 01/14/25 | +2.24% since 01/14/25 |
| Low | 4.36 on 01/15/25 | 267.15 on 01/16/25 | 55.08 on 01/16/25 | 415.13 on 01/15/25 | 90.82 on 01/16/25 |
| High | 5.15 on 01/16/25 | 276.97 on 01/17/25 | 57.68 on 01/21/25 | 432.60 on 01/22/25 | 93.90 on 01/21/25 |
| 1-Month | |||||
| %Chg | +48.59% since 12/20/24 | +3.82% since 12/20/24 | -0.42% since 12/20/24 | +7.74% since 12/20/24 | +0.51% since 12/20/24 |
| Low | 2.92 on 12/26/24 | 257.05 on 01/06/25 | 54.81 on 01/13/25 | 390.92 on 12/23/24 | 88.57 on 01/10/25 |
| High | 5.42 on 01/13/25 | 276.97 on 01/17/25 | 58.38 on 12/27/24 | 432.60 on 01/22/25 | 94.55 on 12/26/24 |
| 3-Month | |||||
| %Chg | +35.43% since 10/22/24 | -14.46% since 10/22/24 | +8.21% since 10/22/24 | -9.88% since 10/22/24 | +5.54% since 10/22/24 |
| Low | 2.20 on 11/19/24 | 253.30 on 12/19/24 | 51.81 on 10/28/24 | 377.85 on 12/19/24 | 86.08 on 11/19/24 |
| High | 5.45 on 10/23/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +2.60% since 07/22/24 | -18.61% since 07/22/24 | +33.79% since 07/22/24 | -13.69% since 07/22/24 | +28.49% since 07/22/24 |
| Low | 2.20 on 11/19/24 | 253.30 on 12/19/24 | 41.90 on 07/23/24 | 377.85 on 12/19/24 | 70.78 on 07/23/24 |
| High | 5.45 on 10/23/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 92,972 | 147,719,456 | 115,687,216 | 110,194,080 | 115,852,888 |
| Shares Outstanding, K | 20,569 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 15,730,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -72,730,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 1,070,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -30,440,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.64 | 0.56 | 0.45 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.80 on 11/06/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 03/06/25 | 02/04/25 | 02/06/25 | 02/03/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | N/A | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 48.11 | 0.00 | 20.73 |